AI assistant
IDEXX LABORATORIES INC /DE — Director's Dealing 2015
Feb 13, 2015
30016_dirs_2015-02-13_4c8b30b8-c721-4d9e-a9a3-42e8db36cef6.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2015-02-11
Reporting Person: AYERS JONATHAN W (Director, Chairman, President & CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-02-11 | Common Stock | M | 29000 | $56.95 | Acquired | 460130 | Direct |
| 2015-02-11 | Common Stock | S | 10218 | $154.0088 | Disposed | 449912 | Direct |
| 2015-02-11 | Common Stock | S | 16231 | $154.8267 | Disposed | 433681 | Direct |
| 2015-02-11 | Common Stock | S | 2551 | $155.7174 | Disposed | 431130 | Direct |
| 2015-02-12 | Common Stock | M | 29245 | $56.95 | Acquired | 460375 | Direct |
| 2015-02-12 | Common Stock | S | 22877 | $156.1584 | Disposed | 437498 | Direct |
| 2015-02-12 | Common Stock | S | 5768 | $156.5888 | Disposed | 431730 | Direct |
| 2015-02-12 | Common Stock | S | 600 | $157.4750 | Disposed | 431130 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-02-11 | Non-Qualified Stock Option (right to buy) | $56.95 | M | 29000 | Disposed | 2015-02-13 | Common Stock (29000) | Direct |
| 2015-02-12 | Non-Qualified Stock Option (right to buy) | $56.95 | M | 29245 | Disposed | 2015-02-13 | Common Stock (29245) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 49000 | Indirect |
Footnotes
F1: The sale reported above was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 02/28/2014.
F2: The sale price reported reflects the weighted average sale price of multiple transactions on the reported date at prices that ranged from $153.32 to $154.31, inclusive. The reporting person hereby undertakes to provide upon request to SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 2 through 7, inclusive, to this Form 4.
F3: The sale price reported reflects the weighted average sale price of multiple transactions on the reported date at prices that ranged from $154.32 to $155.31, inclusive.
F4: The sale price reported reflects the weighted average sale price of multiple transactions on the reported date at prices that ranged from $155.38 to $155.83, inclusive.
F5: The sale price reported reflects the weighted average sale price of multiple transactions on the reported date at prices that ranged from $155.46 to $156.45, inclusive.
F6: The sale price reported reflects the weighted average sale price of multiple transactions on the reported date at prices that ranged from $156.46 to $156.84, inclusive.
F7: The sale price reported reflects the weighted average sale price of multiple transactions on the reported date at prices that ranged from $157.46 to $157.49, inclusive.
F8: Grant of options to buy shares of common stock that became exercisable as to 12,000 shares on 02/14/2009, 02/14/2010, 02/14/2011 and 02/14/2012, and 10,245 shares on 02/14/2013.